Funding
← Back to your selection

Neurimmune

Activity from announced rounds

Activity in this selectionthe-family-fund-075bdd15
Rounds participated in
1
Confirmed lead rounds
1
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$29.5M
1 disclosed · full round size, not this investor’s share

By stage

Series B1

By primary sector

Biotech1

By country

Switzerland1

Rounds

1 in this selection
NovaGo Therapeutics

NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury.

CHF 24MSeries B
Lead